CDI-988 is a direct-acting, oral antiviral being developed for norovirusNorovirus challenge study is underway at Emory University School of ...
To date, there are no approved vaccines or antiviral treatments for human norovirus, the leading cause of acute gastroenteritis outbreaks worldwide with more than 685 million infections each year.
CDI‑988 is the first oral antiviral drug candidate being developed for prevention and treatment of norovirus infectionsCompany to present Phase 1 data and updates from ongoing Phase 1b study conducted ...
Cocrystal Pharma, Inc. announced that its investigational antiviral drug CDI-988 has shown strong efficacy against the newly dominant norovirus variants GII.17 and previously prevalent GII.4, amid a ...
Subject enrollment expected to begin in Q1 2026 CDI-988 is the first oral broad-spectrum antiviral drug candidate for potential prevention of norovirus outbreaks and treatment of acute viral ...
The highly contagious norovirus – popularly known as "stomach flu" or the "winter vomiting bug" – is now surging through the U.S. The number of outbreaks is up significantly over previous years, ...
Scientists at The University of Texas at Austin, in collaboration with researchers from the University of North Carolina at Chapel Hill and the National Institutes of Health, have discovered a ...
Norovirus is notoriously hard to kill. The CDC recommends washing your hands vigorously with soap. (Mike Kemp / Getty Images / Blend Images) A nasty, highly contagious virus is spreading across the ...
A nasty, highly contagious virus is spreading across the country ahead of the holiday season — and it’s not the flu or Covid. Norovirus, also called the “winter vomiting disease,” has been rising ...
Restaurant and food retailers across the United States are being warned of a potential norovirus contamination in seafood that was harvested between Feb. 13 and March 3.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results